Stock listing
Lang & Schwarz:A2PGL8 Filana Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of Filana Therapeutics, Inc. · home listing NASDAQ:FLNA
Follow Filana Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:FLNA
$0.561 USD -0.061 (-9.8%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:FLNA
- Day range
- $0.560 – $0.630 USDNov 2, 2026
- Volume
- 544,958 sharesNov 2, 2026
- Market cap
- $27.10M USDAt the close on Nov 2, 2026 · price × 48.31M shares outstanding
- 52-week range
- $0.560 – $3.450 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.95M USDMedian day 311,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FLNA · Home | $0.561 USD | -0.061 (-9.8%) | 544,958 | $0.630 | $0.630 | $0.560 | $0.622 | Close on Nov 2, 2026 |
| Frankfurt:PX91 | €0.571 EUR | +0.035 (+6.5%) | — | €0.571 | €0.571 | €0.571 | €0.536 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:FLNA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.561 | -0.061 | -9.8% | $0.630 | $0.630 | $0.560 | 544,958 | |
| $0.622 | -0.038 | -5.8% | $0.659 | $0.659 | $0.620 | 214,783 | |
| $0.660 | +0.010 | +1.5% | $0.660 | $0.680 | $0.650 | 264,400 | |
| $0.650 | 0.000 | 0.0% | $0.660 | $0.660 | $0.630 | 347,000 | |
| $0.650 | +0.040 | +6.6% | $0.620 | $0.650 | $0.610 | 295,500 | |
| $0.610 | -0.030 | -4.7% | $0.630 | $0.640 | $0.600 | 297,000 | |
| $0.640 | -0.010 | -1.5% | $0.640 | $0.650 | $0.620 | 311,100 | |
| $0.650 | -0.010 | -1.5% | $0.660 | $0.670 | $0.640 | 250,100 | |
| $0.660 | -0.030 | -4.3% | $0.690 | $0.710 | $0.650 | 305,800 | |
| $0.690 | +0.010 | +1.5% | $0.670 | $0.700 | $0.670 | 198,400 | |
| $0.680 | -0.020 | -2.9% | $0.710 | $0.710 | $0.680 | 256,700 | |
| $0.700 | -0.060 | -7.9% | $0.750 | $0.760 | $0.700 | 327,900 | |
| $0.760 | +0.030 | +4.1% | $0.710 | $0.770 | $0.700 | 248,500 | |
| $0.730 | -0.010 | -1.4% | $0.730 | $0.740 | $0.720 | 253,200 | |
| $0.740 | -0.030 | -3.9% | $0.760 | $0.770 | $0.740 | 323,500 | |
| $0.770 | -0.050 | -6.1% | $0.810 | $0.810 | $0.760 | 360,400 | |
| $0.820 | +0.010 | +1.2% | $0.820 | $0.840 | $0.800 | 407,900 | |
| $0.810 | -0.010 | -1.2% | $0.800 | $0.820 | $0.780 | 610,800 | |
| $0.820 | -0.050 | -5.7% | $0.850 | $0.850 | $0.790 | 759,200 | |
| $0.870 | 0.000 | 0.0% | $0.890 | $0.900 | $0.830 | 670,000 | |
| $0.870 | -0.060 | -6.5% | $0.920 | $0.930 | $0.870 | 1,034,800 | |
| $0.930 | -0.040 | -4.1% | $0.970 | $1.040 | $0.930 | 1,691,200 | |
| $0.970 | +0.080 | +9.0% | $1.000 | $1.030 | $0.930 | 2,804,700 | |
| $0.890 | -0.030 | -3.3% | $0.930 | $0.950 | $0.860 | 769,500 | |
| $0.920 | +0.070 | +8.2% | $0.850 | $0.940 | $0.830 | 1,202,500 | |
| $0.850 | +0.100 | +13.3% | $0.730 | $0.890 | $0.720 | 2,053,900 | |
| $0.750 | -0.020 | -2.6% | $0.780 | $0.780 | $0.740 | 771,900 | |
| $0.770 | -0.100 | -11.5% | $0.850 | $0.900 | $0.740 | 2,313,600 | |
| $0.870 | -0.160 | -15.5% | $1.000 | $1.000 | $0.800 | 5,466,900 | |
| $1.030 | +0.290 | +39.2% | $0.980 | $1.300 | $0.900 | 94,301,500 | |
| $0.740 | +0.010 | +1.4% | $0.740 | $0.770 | $0.730 | 336,500 | |
| $0.730 | +0.010 | +1.4% | $0.720 | $0.730 | $0.710 | 122,800 | |
| $0.720 | +0.040 | +5.9% | $0.690 | $0.720 | $0.680 | 274,500 | |
| $0.680 | -0.020 | -2.9% | $0.690 | $0.700 | $0.670 | 379,600 | |
| $0.700 | -0.020 | -2.8% | $0.730 | $0.730 | $0.680 | 446,000 | |
| $0.720 | -0.050 | -6.5% | $0.770 | $0.770 | $0.710 | 379,300 | |
| $0.770 | -0.040 | -4.9% | $0.810 | $0.810 | $0.770 | 309,600 | |
| $0.810 | 0.000 | 0.0% | $0.800 | $0.810 | $0.770 | 303,300 | |
| $0.810 | +0.010 | +1.3% | $0.790 | $0.810 | $0.760 | 271,300 | |
| $0.800 | -0.020 | -2.4% | $0.810 | $0.820 | $0.750 | 509,500 | |
| $0.820 | -0.010 | -1.2% | $0.820 | $0.850 | $0.800 | 285,400 | |
| $0.830 | -0.030 | -3.5% | $0.890 | $0.890 | $0.820 | 273,200 | |
| $0.860 | 0.000 | 0.0% | $0.900 | $0.900 | $0.820 | 347,200 | |
| $0.860 | -0.040 | -4.4% | $0.900 | $0.900 | $0.850 | 217,000 | |
| $0.900 | -0.030 | -3.2% | $0.920 | $0.930 | $0.880 | 139,700 | |
| $0.930 | +0.010 | +1.1% | $0.930 | $0.930 | $0.910 | 169,900 | |
| $0.920 | 0.000 | 0.0% | $0.910 | $0.940 | $0.910 | 110,300 | |
| $0.920 | -0.029 | -3.0% | $0.940 | $0.940 | $0.920 | 56,800 | |
| $0.949 | +0.019 | +2.0% | $0.919 | $0.957 | $0.913 | 110,136 | |
| $0.930 | -0.030 | -3.1% | $0.950 | $0.951 | $0.920 | 121,940 | |
| $0.960 | +0.020 | +2.1% | $0.950 | $0.960 | $0.940 | 106,200 | |
| $0.940 | -0.030 | -3.1% | $0.950 | $0.980 | $0.910 | 167,700 | |
| $0.970 | +0.100 | +11.5% | $0.890 | $0.990 | $0.870 | 545,200 | |
| $0.870 | -0.020 | -2.2% | $0.890 | $0.890 | $0.850 | 404,000 | |
| $0.890 | -0.020 | -2.2% | $0.930 | $0.930 | $0.890 | 215,000 | |
| $0.910 | -0.040 | -4.2% | $0.950 | $0.950 | $0.910 | 291,700 | |
| $0.950 | +0.020 | +2.2% | $0.930 | $0.970 | $0.930 | 162,100 | |
| $0.930 | -0.040 | -4.1% | $0.960 | $0.980 | $0.920 | 247,100 | |
| $0.970 | -0.030 | -3.0% | $1.010 | $1.040 | $0.960 | 276,100 | |
| $1.000 | 0.000 | 0.0% | $0.970 | $1.050 | $0.970 | 526,300 | |
| $1.000 | +0.040 | +4.2% | $0.960 | $1.030 | $0.930 | 614,400 | |
| $0.960 | 0.000 | 0.0% | $0.950 | $0.990 | $0.930 | 422,400 | |
| $0.960 | -0.040 | -4.0% | $1.000 | $1.000 | $0.950 | 173,800 | |
| $1.000 | -0.030 | -2.9% | $1.030 | $1.030 | $0.980 | 394,200 | |
| $1.030 | +0.020 | +2.0% | $1.020 | $1.040 | $1.000 | 324,100 |
- Ticker
- Lang & Schwarz:A2PGL8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Latest news
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Oct 28, 2026
Closed $0.65 (0.0%) on Oct 28, 2026
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
Sep 22, 2026
Closed $1.03 (+39.2%) on Sep 22, 2026
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
Jul 29, 2026
Closed $0.87 (-1.1%) on Jul 29, 2026
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
May 7, 2026
Closed $1.36 (-5.6%) on May 7, 2026
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
May 5, 2026
Closed $1.38 (-1.4%) on May 5, 2026
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
Apr 15, 2026
Closed $1.61 (+1.3%) on Apr 15, 2026
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 12, 2026
Closed $1.95 (-6.7%) on Mar 12, 2026
Filana Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 7 in all · newest Oct 28, 2026 · oldest 2026
Where Filana Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FLNA · Home listing | NASDAQ | United States | USD |
| gettex:PX91 | gettex | Germany | EUR |
| LS Exchange:A2PGL8 | LS Exchange | Germany | EUR |
| BOATS:FLNA | BOATS | United States | USD |
| Lang & Schwarz:A2PGL8 · This page | Lang & Schwarz | Germany | EUR |
| Tradegate:PX91 | Tradegate | Germany | EUR |
| BMV:FLNA | BMV | Mexico | MXN |
| Frankfurt:PX91 | Frankfurt | Germany | EUR |
| Dusseldorf:PX91 | Dusseldorf | Germany | EUR |
| Hamburg:PX91 | Hamburg | Germany | EUR |
| Munich:PX91 | Munich | Germany | EUR |
| Stuttgart:PX91 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Filana Therapeutics, Inc.